Last reviewed · How we verify
NCT06853899
Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health
NA trial testing Truology A2 in Skin Hydration in 33 participants. Completed in 10 January 2025.
10 January 2025
Quick facts
| Lead sponsor | Truology |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 33 |
| Start date | 21 October 2024 |
| Primary completion | 10 January 2025 |
| Estimated completion | 10 January 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Truology A2
- Truology C-Boost
- Truology Barrier Restore
Conditions studied
- Skin Hydration — all drugs for Skin Hydration →
- Skin Aging — all drugs for Skin Aging →
Sponsor
Truology
Who can join
Adults 35 to 55, female only, with Skin Hydration or Skin Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial evaluates the efficacy of three skincare products-Truology A2 (0.2% Retinaldehyde Serum), Truology C-Boost, and Truology Barrier Restore-in improving skin quality and health. The study will assess improvements in skin firmness, evenness, brightness, hydration, fine lines/wrinkles, redness, and skin stress/irritation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06853899
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Hydration
Currently open trials in the same condition.
- NCT07493850 — Study to Assess the Efficacy of EMC-CAP-2025A on Age-Related Skin Parameters in Healthy Individuals · Phase 2 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06853899 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Truology
- Last refreshed: 3 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06853899.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing